Form 4: Elevance Health Director Susan D. DeVore Reports Stock Acquisition and Disposal

Director Susan D. DeVore reports acquiring deferred stock units and disposing of common stock in Elevance Health, Inc.

Summary

• Susan D. DeVore, a director of Elevance Health, Inc., filed a Form 4 detailing changes in beneficial ownership.
• On May 14, 2025, DeVore acquired 601 deferred stock units under the company's Board of Directors Compensation Program.
• On the same date, DeVore disposed of 2,302 shares of common stock.
• Following these transactions, DeVore beneficially owns 2,302 shares of common stock.
• The deferred stock units are payable in company common stock upon the earlier of five years from the grant date or cessation of board membership, unless a later date is designated.

Sentiment

Score: 5

Explanation: The document is a routine regulatory filing detailing stock transactions by a company director, with no inherent positive or negative sentiment.

Future Outlook

The deferred stock units will be payable in company common stock upon the earlier of five years from the grant date or cessation of board membership, unless a later date is designated.

Industry Context

Form 4 filings are standard disclosures required by the SEC to provide transparency into the transactions of company insiders, such as directors and officers, ensuring fair market practices.

Key Dates

Keywords

Form 4, Beneficial Ownership, Elevance Health, Director, Stock Acquisition, Stock Disposal, Deferred Stock Units, ELV